Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
P: 202.249.7100
E: [email protected]
Anand Saxena is the Director of Regulatory Affairs at Cipla Limited. Anand is post graduate in Organic Chemistry. He has more than 23 years of experience in Regulatory Affairs. In his current responsibilities include managing and leading team in regulatory activities related to pre IND, Pre ANDA, controlled correspondence, PFC submission, ANDA filing and NDA filing. Handling deficiency review and submission. Regulatory support on handling product launch and Post approval life cycle management. Providing support in terms of regulatory strategies during new product selection for development, due diligence, labeling, product launch, and publishing. His experience in regulatory includes different dosage forms including complex injectable, topical, ophthalmic, respiratory inhalation, inhalers and nasal sprays etc.